drugset / Trial / NCT06278766

A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration

NCT06278766 ↗

Phase 1 Completed 8 enrolled AbbVie
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of \[14C\] ABBV-552 in healthy, male volunteers following administration of a single oral dose.

Timeline

Start
2024-02-21
Primary completion
2024-04-19
Completion
2024-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject PLOSARACETAM Small molecule — Oral

Indications

No indication recorded.